Cancer News

Classification can lead to new ways to diagnose, treat cancerFeb 12, 2018
A novel approach to studying cancer has enabled researchers to group about 10,000 human cancers of 32 different types into 10 classes based on the molecular pathways that drive tumor growth.
Immunotherapy summit brings together patients, expertsJan 11, 2018
The NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine is hosting a free educational program for cancer patients and their caregivers seeking to learn more about cancer immunotherapy and clinical trials.
Research reveals path to ependymoma chemotherapyJan 4, 2018
Dr. Stephen Mack and colleagues have developed a framework for discovering targets in ependymomas, and other cancer that lack known genetic drivers, thereby also providing insights into treatment strategies.
G-quadruplex regulates breast cancer-associated geneDec 21, 2017
Researchers have now discovered a mechanism by which cells can regulate switching between the two proteins, opening options for the development of novel therapeutic strategies to control cancer growth in the future.
Dr. Jeffery Rosen honored for breast cancer research Dec 8, 2017
Dr. Jeffrey Rosen was awarded the American Association for Cancer Research (AACR) Distinguished Lecture in Breast Cancer Research at the San Antonio Breast Cancer Symposium.
Dr. Matthew Ellis named to Forbes’ “Physician Honor Roll"Dec 5, 2017
Dr. Matthew Ellis is one of 27 breast oncologists across the country being recognized by Forbes as an exemplary physician in the field of breast cancer oncology.
Dr. Trey Westbrook named new McNair ScholarDec 5, 2017
Dr. Trey Westbrook has been named the newest McNair Scholar. This recognition will support his work focused on discovering the genes and mechanisms that drive breast cancer and developing the next generation of cancer medicines.
Alex’s Lemonade Stand funds Phase 1 neuroblastoma trialDec 4, 2017
Dr. Andras Heczey and Dr. Leonid Metelitsa received a $1.5 million grant from Alex’s Lemonade Stand Foundation to conduct a first-in-human Phase 1 Neuroblastoma clinical trial.
Baylor only Texas site awarded NCI grant to help end smokingNov 28, 2017
The Dan L Duncan Comprehensive Cancer Center is the only site in the state of Texas that will implement a National Cancer Institute-funded tobacco cessation program for cancer patients.
Managing cancer treatment and holiday season expectationsNov 17, 2017
Experts from Baylor College of Medicine provide guidance to help manage cancer during the holidays, as both a patient and a caregiver.